The impact of SPC Manufacturing Waiver on jobs, competitiveness & patient access to medicines

16th Biosimilar Medicines Conference

14th Legal Affairs Conference

17th Regulatory and Scientific Affairs Conferenc

11th Medicines for Europe Pharmacovigilance Conference

IGBA 2017 achievements – Adrian van den Hoven

Life Science Industry Coalition Position paper

Educational material on biosimilar medicines, developed by IGBA (International Generic and Biosimilar Medicines Association)

How come that biosimilar medicines are still heavily debated today?

What is needed to familiarize oncologists with biosimilar medicines?